检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:邵彩红[1] 王蕊[2] 王渊铭[2] 王豪[2] 姚建华[2] 陈德[2]
机构地区:[1]同济大学附属东方医院急诊内科,上海200120 [2]同济大学附属杨浦医院心内科,上海200090
出 处:《现代生物医学进展》2015年第18期3551-3554,3477,共5页Progress in Modern Biomedicine
基 金:上海市卫生局基金项目(20124Y103);同济大学附属杨浦医院基金项目(SE1201214)
摘 要:目的:观察血清胱抑素C(Cystatin C,Cys C)在阿托伐他汀治疗早期心肾综合征中的变化,探讨Cys C在阿托伐他汀治疗早期心肾综合征中的临床意义。方法:选择90例慢性心功能不全引起的早期心肾综合征患者,随机分为常规治疗组(A组)、阿托伐他汀20 mg组(B组)以及阿托伐他汀40 mg组(C组)各30例。常规治疗组给予常规抗心力衰竭药物治疗,阿托伐他汀组在常规抗心衰药物治疗基础上分别加用阿托伐他汀20 mg/d或者阿托伐他汀40 mg/d口服。分别测定其治疗3个月前后Scr、GFR、Cys C水平并进行组间比较。结果:治疗3个月后,A组、B组Scr及GFR分别与治疗前比较差异无显著性(P>0.05),C组Scr及GFR与治疗前比较差异有显著性(P<0.05);治疗3个月后,A组Cys C与治疗前比较差异无显著性(P>0.05),B组、C组Cys C与治疗前比较差异有显著性(P<0.01)。结论:在阿托伐他汀治疗早期心肾综合征疗效观察中,Cys C较Scr更能敏感反应早期肾功能变化情况。Objective: To investigate the change of serum Cystatin C(Cys C) in early cardiorenal syndrome treated with atorvastatin and its clinical significance. Methods: 90 patients with chronic heart failure caused by early cardiorenal syndrome were randomly divided into conventional treatment group(group A, n = 30), atorvastatin 20 mg group(group B, n = 30) and atorvastatin 40 mg group(group C, n = 30). The conventional treatment group received conventional anti-heart failure drug therapy, atorvastatin group was treated with atorvastatin 20 mg/d or atorvastatin 40 mg/d orally on a regular basis. The level of Scr, GFR, Cys C was observed before treatment and 3 months after treatment. Results: The level of Scr and GFR in group A and B after 3 months of treatment had no difference compared with before treatment(P〉 0.05); but in group C, Scr and GFR showed difference after treatment with statistical significance(P〈 0.05); after 3 months of treatment, Cys C level in group A had no significant difference compared with before treatment(P〈 0.05), while it showed a significant difference in group B and group C compared with before treatment(P〉0.01). Conclusions: Cys C is more sensitive to early change of renal function than Scr in the curative observation of early cardiorenal syndrome treated with atorvastatin.
分 类 号:R541.61[医药卫生—心血管疾病] R692.5[医药卫生—内科学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222